메뉴 건너뛰기




Volumn 11, Issue 2, 2000, Pages 177-187

A combination of low doses of 17β-estradiol and norethisterone acetate prevents bone loss and normalizes bone turnover in postmenopausal women

Author keywords

17 estradiol; Biochemical bone markers; Bone mineral density; Norethisterone acetate; Postmenopausal osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; COLLAGEN TYPE 1; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; NORETHISTERONE ACETATE; OSTEOCALCIN; PYRIDINOLINE; UNCLASSIFIED DRUG;

EID: 0034066108     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00004180     Document Type: Article
Times cited : (70)

References (30)
  • 1
    • 0027222768 scopus 로고
    • Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis
    • Peck WA, Burckhardt P, Christiansen C, et al. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646-50.
    • (1993) Am J Med , vol.94 , pp. 646-650
    • Peck, W.A.1    Burckhardt, P.2    Christiansen, C.3
  • 2
    • 0028786315 scopus 로고
    • Determinants of reduced survival following hip fracture in men: A controlled, population-based study
    • Poór G, Atkinson EJ, O'Fallon WM, Melton LJ. Determinants of reduced survival following hip fracture in men: a controlled, population-based study. Clin Orthop 1995;319:260-5.
    • (1995) Clin Orthop , vol.319 , pp. 260-265
    • Poór, G.1    Atkinson, E.J.2    O'Fallon, W.M.3    Melton, L.J.4
  • 4
    • 0021717406 scopus 로고
    • Relative contributions of aging and estrogen deficiency to postmenopausal bone loss
    • Richelson LS, Wahner HW, Melton LJ III, Riggs BL. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med 1984;311:1273-5.
    • (1984) N Engl J Med , vol.311 , pp. 1273-1275
    • Richelson, L.S.1    Wahner, H.W.2    Melton III, L.J.3    Riggs, B.L.4
  • 5
    • 0030034911 scopus 로고    scopus 로고
    • Sex steroids, bone mass, and bone loss: A prospective study of premenopausal, perimenopausal, and postmenopausal women
    • Slemenda C, Longcope C, Peacock M, Hui S, Johnston CC. Sex steroids, bone mass, and bone loss: a prospective study of premenopausal, perimenopausal, and postmenopausal women. J Clin Invest 1996;97:14-21.
    • (1996) J Clin Invest , vol.97 , pp. 14-21
    • Slemenda, C.1    Longcope, C.2    Peacock, M.3    Hui, S.4    Johnston, C.C.5
  • 6
    • 0031043696 scopus 로고    scopus 로고
    • High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women
    • Ravn P, Rix M, Andreasen H, Clemmesen B, Bidstrup M, Gunnes M. High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women. Calcif Tissue Int 1997;60:255-60.
    • (1997) Calcif Tissue Int , vol.60 , pp. 255-260
    • Ravn, P.1    Rix, M.2    Andreasen, H.3    Clemmesen, B.4    Bidstrup, M.5    Gunnes, M.6
  • 7
    • 0019208916 scopus 로고
    • Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen
    • Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1980;303:1195-8.
    • (1980) N Engl J Med , vol.303 , pp. 1195-1198
    • Weiss, N.S.1    Ure, C.L.2    Ballard, J.H.3    Williams, A.R.4    Daling, J.R.5
  • 9
    • 0023229530 scopus 로고
    • Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study
    • Kiel DP, Felson DT, Anderson JJ, Wilson PW, Moskowitz MA. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med 1987;317:1169-74.
    • (1987) N Engl J Med , vol.317 , pp. 1169-1174
    • Kiel, D.P.1    Felson, D.T.2    Anderson, J.J.3    Wilson, P.W.4    Moskowitz, M.A.5
  • 10
    • 0025332828 scopus 로고
    • Hormone replacement therapy and the risk for first hip fracture: A prospective, population-based cohort study
    • Naessén T, Persson I, Adami H-O, Bergström R, Bergkvist L. Hormone replacement therapy and the risk for first hip fracture: a prospective, population-based cohort study. Ann Intern Med 1990;113:95-103.
    • (1990) Ann Intern Med , vol.113 , pp. 95-103
    • Naessén, T.1    Persson, I.2    Adami, H.-O.3    Bergström, R.4    Bergkvist, L.5
  • 11
    • 0021964389 scopus 로고
    • Long-term estrogen replacement therapy prevents bone loss and fractures
    • Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985;102:319-24.
    • (1985) Ann Intern Med , vol.102 , pp. 319-324
    • Ettinger, B.1    Genant, H.K.2    Cann, C.E.3
  • 12
    • 0028885330 scopus 로고
    • Fracture protection provided by long-term estrogen treatment
    • Maxim P, Ettinger B, Spitalny GM. Fracture protection provided by long-term estrogen treatment. Osteoporos Int 1995;5:23-9.
    • (1995) Osteoporos Int , vol.5 , pp. 23-29
    • Maxim, P.1    Ettinger, B.2    Spitalny, G.M.3
  • 13
    • 0028860231 scopus 로고
    • Estrogen replacement therapy and fractures in older women
    • Study of Osteoporotic Fractures Research Group
    • Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR. Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 1995;122:9-16.
    • (1995) Ann Intern Med , vol.122 , pp. 9-16
    • Cauley, J.A.1    Seeley, D.G.2    Ensrud, K.3    Ettinger, B.4    Black, D.5    Cummings, S.R.6
  • 14
    • 0026691295 scopus 로고
    • Treatment of postmenopausal osteoporosis with transdermal estrogen
    • Lufkin EG, Wahner HW, O'Fallon WM, et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 1992;117:1-9.
    • (1992) Ann Intern Med , vol.117 , pp. 1-9
    • Lufkin, E.G.1    Wahner, H.W.2    O'Fallon, W.M.3
  • 15
    • 0023946106 scopus 로고
    • Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: A double blind placebo controlled study
    • Munk-Jensen N, Nielsen SP, Obel EB, Eriksen PB. Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: a double blind placebo controlled study. BMJ 1988;296:1150-2.
    • (1988) BMJ , vol.296 , pp. 1150-1152
    • Munk-Jensen, N.1    Nielsen, S.P.2    Obel, E.B.3    Eriksen, P.B.4
  • 16
    • 0019464605 scopus 로고
    • Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy
    • Christiansen C, Christensen MS, Transbøl I. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet 1981;1:459-61.
    • (1981) Lancet , vol.1 , pp. 459-461
    • Christiansen, C.1    Christensen, M.S.2    Transbøl, I.3
  • 17
    • 0028363006 scopus 로고
    • Magnitude and pattern of skeletal response to long term continuous and cyclic sequential oestrogen/progestin treatment
    • Nielsen SP, Bärenholdt O, Hermansen F, Munk-Jensen N. Magnitude and pattern of skeletal response to long term continuous and cyclic sequential oestrogen/progestin treatment. Br J Obstet Gynaecol 1994;101:319-24.
    • (1994) Br J Obstet Gynaecol , vol.101 , pp. 319-324
    • Nielsen, S.P.1    Bärenholdt, O.2    Hermansen, F.3    Munk-Jensen, N.4
  • 18
    • 0030999333 scopus 로고    scopus 로고
    • Effects on bone mass after eight years of hormonal replacement therapy
    • Eiken P, Nielsen SP, Kolthoff N. Effects on bone mass after eight years of hormonal replacement therapy. Br J Obstet Gynaecol 1997;104:702-7.
    • (1997) Br J Obstet Gynaecol , vol.104 , pp. 702-707
    • Eiken, P.1    Nielsen, S.P.2    Kolthoff, N.3
  • 19
    • 0026543449 scopus 로고
    • Low-dosage micronized 17β-estradiol prevents bone loss in postmenopausal women
    • Ettinger B, Genant HK, Steiger P, Madvig P. Low-dosage micronized 17β-estradiol prevents bone loss in postmenopausal women. Am J Obstet Gynecol 1992;166:479-88.
    • (1992) Am J Obstet Gynecol , vol.166 , pp. 479-488
    • Ettinger, B.1    Genant, H.K.2    Steiger, P.3    Madvig, P.4
  • 20
    • 0022412159 scopus 로고
    • Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis
    • Christiansen C, Nilas L, Riis BJ, Rødbro P, Deftos L. Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis. Lancet 1985;II: 800-1.
    • (1985) Lancet , vol.2 , pp. 800-801
    • Christiansen, C.1    Nilas, L.2    Riis, B.J.3    Rødbro, P.4    Deftos, L.5
  • 21
    • 0346344235 scopus 로고    scopus 로고
    • Prevention of bone loss with alendronate in postmenopausal women under 60 years of age
    • Hosking D, Chilvers CE, Christiansen C, et al. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. N Engl J Med 1998;338:485-92.
    • (1998) N Engl J Med , vol.338 , pp. 485-492
    • Hosking, D.1    Chilvers, C.E.2    Christiansen, C.3
  • 22
    • 0024997302 scopus 로고
    • 17β-Estradiol and continuous norethisterone: A unique treatment for established osteoporosis in elderly women
    • Christiansen C, Riis BJ. 17β-Estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women. J Clin Endocrinol Metab 1990;71:836-41.
    • (1990) J Clin Endocrinol Metab , vol.71 , pp. 836-841
    • Christiansen, C.1    Riis, B.J.2
  • 23
    • 0028618208 scopus 로고
    • Compliance to hormone replacement therapy in menopausal women controlled in a third level academic centre
    • Cano A. Compliance to hormone replacement therapy in menopausal women controlled in a third level academic centre. Maturitas 1995;20:91-9.
    • (1995) Maturitas , vol.20 , pp. 91-99
    • Cano, A.1
  • 24
    • 0027996333 scopus 로고
    • Women's concerns with hormone replacement therapy: Compliance issues
    • Hammond CB. Women's concerns with hormone replacement therapy: compliance issues. Fertil Steril 1994;6(Suppl 2):S157-60.
    • (1994) Fertil Steril , vol.6 , Issue.2 SUPPL.
    • Hammond, C.B.1
  • 25
    • 0028336972 scopus 로고
    • Compliance problems with hormone replacement therapy
    • Stumpf PG, Trolice MP. Compliance problems with hormone replacement therapy. Obstet Gynecol Clin North Am 1994;21:219-29.
    • (1994) Obstet Gynecol Clin North Am , vol.21 , pp. 219-229
    • Stumpf, P.G.1    Trolice, M.P.2
  • 26
    • 0032169355 scopus 로고    scopus 로고
    • Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms?
    • Bærug U, Winge T, Nordland G, Faber-Swensson E, Heldaas K, Norling B, et al. Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms? Climacteric 1998;1:219-28.
    • (1998) Climacteric , vol.1 , pp. 219-228
    • Bærug, U.1    Winge, T.2    Nordland, G.3    Faber-Swensson, E.4    Heldaas, K.5    Norling, B.6
  • 27
    • 0030007290 scopus 로고    scopus 로고
    • 17β-Estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy
    • Stadberg E, Mattsson L-Å, Uvebrant M. 17β-Estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy. Maturitas 1996;23:31-9.
    • (1996) Maturitas , vol.23 , pp. 31-39
    • Stadberg, E.1    Mattsson, L.-Å.2    Uvebrant, M.3
  • 28
    • 0028586042 scopus 로고
    • Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment
    • Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994;79:1693-1700.
    • (1994) J Clin Endocrinol Metab , vol.79 , pp. 1693-1700
    • Garnero, P.1    Shih, W.J.2    Gineyts, E.3    Karpf, D.B.4    Delmas, P.D.5
  • 29
    • 0002215221 scopus 로고    scopus 로고
    • Utility of biochemical markers of bone resorption in osteoporosis
    • Marcus R, Feldman D, Kelsey J, editors. New York: Academic Press
    • Delmas PD, Garnero P. Utility of biochemical markers of bone resorption in osteoporosis. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. New York: Academic Press, 1996:1075-88.
    • (1996) Osteoporosis , pp. 1075-1088
    • Delmas, P.D.1    Garnero, P.2
  • 30
    • 0025303668 scopus 로고
    • Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists?
    • Riis BJ, Christiansen C, Johansen JS, Jacobson J. Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists? J Clin Endocrinol Metab 1990;70:920-4.
    • (1990) J Clin Endocrinol Metab , vol.70 , pp. 920-924
    • Riis, B.J.1    Christiansen, C.2    Johansen, J.S.3    Jacobson, J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.